1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:PPVs And NPVs at different levels of assumed prevalence for identifying mass effect and vasogenic edemaa
Assumed Prevalence Thin Series Thick Series PPV (95% CI) NPV (95% CI) PPV (95% CI) NPV (95% CI) Mass effect 0.05 33.2 (24.7–48.7) 99.8 (99.7–99.9) 42.1 (31.6–58.7) 99.7 (99.6–99.8) 0.10 51.2 (40.9–66.7) 99.6 (99.4–99.8) 60.6 (49.4–75.0) 99.4 (99.2–99.6) 0.15 62.5 (52.4–76.1) 99.3 (99.0–99.6) 70.9 (60.8–82.7) 99.1 (98.8–99.4) 0.20 70.3 (60.9–81.8) 99.1 (98.6–99.5) 77.6 (68.7–87.1) 98.8 (98.3–99.2) Vasogenic edema 0.05 42.3 (29.1–68.9) 99.4 (99.0–99.9) 51.4 (38.7–72.1) 99.5 (99.1–99.7) 0.10 60.7 (46.4–82.4) 98.8 (97.9–99.7) 69.1 (57.1–84.5) 98.9 (98.1–99.5) 0.15 71.1 (57.9–88.1) 98.2 (96.7–99.6) 78.0 (67.9–89.6) 98.2 (97.0–99.2) 0.20 77.7 (66.1–91.3) 97.4 (95.3–99.4) 83.4 (75.0–92.5) 97.4 (95.9–98.8)
↵a These measurements are based on the same operating points used to determine sensitivity and specificity in Table 1.